Accueil・Liste d'Actions・Medtronic PLC

Medtronic PLC

Fermé

SecteurSoins de santé

91.22 0.78

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

90.18

Max

91.97

Chiffres clés
By Trading Economics
Revenu	130M 1.3B
Ventes	789M 9.8B
P/E Moyenne du Secteur	23.345 57.002
BPA	1.55
Rendement du dividende	3.26
Marge bénéficiaire	12.981
Employés	95,000
EBITDA	147M 2.6B

Recommandations
By TipRanks
Recommandations	Achat
Prévisions sur 12 Mois	+5.46% upside

Dividendes
By Acuity
Rendement du dividende Moyenne du Secteur	3.26% 2.22%
Prochains Résultats	1 sept. 2026
Date du Prochain Dividende	16 oct. 2026
Date du Prochain Détachement de Dividende	25 sept. 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	14B 109B
Ouverture précédente	90.44
Clôture précédente	91.22

Sentiment de l'Actualité

By Acuity

20%

80%

58 / 340 Classement par Healthcare

Medtronic PLC Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

14 août 2026, 21:51 UTC

Medtronic PLC shares are lower in after-market hours, with no specific news cited. Broader market declines follow a report of falling U.S. retail sales.

13 août 2026, 23:01 UTC

Medtronic PLC shares are lower in after-market hours, continuing a decline from earlier losses amid mixed signals on labor market strength and inflation.

12 août 2026, 23:01 UTC

Medtronic PLC shares are lower in after-market trading, reflecting a retracement from an earlier peak while remaining above the 20-day moving average.

11 août 2026, 23:01 UTC

Shares of Medtronic PLC were lower during after-market hours, despite a brief uptick earlier in the session. No specific news was identified.

10 août 2026, 23:21 UTC

Medtronic PLC shares are higher in after-market trading, continuing an upward trend since Monday's close and remaining above the 20-day moving average.

8 août 2026, 00:02 UTC

Medtronic PLC shares are lower in after-market hours amid a volatile session. A weak jobs report has influenced broader market expectations for interest rate hikes.

7 août 2026, 23:26 UTC

Medtronic PLC shares are higher in after-market hours, supported by overall market strength and strong performances from major tech stocks.

6 août 2026, 20:06 UTC

News

Medtronic PLC announced expanded CE Mark approval for its Sphere-9 Catheter, yet shares are trading lower since Wednesday's close after an earlier uptick.

5 août 2026, 19:52 UTC

News

Medtronic PLC shares are lower today amid increased put options volume, reflecting bearish sentiment ahead of the upcoming earnings report on September 1st.

4 août 2026, 20:06 UTC

News

Medtronic PLC shares are lower after a jury ruled the company owes $88 million for damages related to Covidien's hernia mesh products.

3 août 2026, 23:02 UTC

Medtronic PLC shares are lower in after-market hours, reflecting selling pressure despite trading above its 20-day moving average. No specific news was identified.

31 juil. 2026, 23:46 UTC

Medtronic PLC shares are trading higher in after-market hours, following unusual trading activity and amid rising U.S. Treasury yields and crude oil prices.

30 juil. 2026, 23:31 UTC

Medtronic PLC shares are modestly higher in after-market trading, remaining near the upper end of their one-month range. No specific news was identified.

29 juil. 2026, 21:51 UTC

Medtronic PLC shares are lower in after-market hours, reflecting broader market declines amid renewed inflation and interest rate concerns linked to rising crude oil prices.

28 juil. 2026, 23:26 UTC

Shares of Medtronic PLC are trading higher in after-market hours, maintaining above the 20-day moving average amid a trend of five consecutive daily gains.

27 juil. 2026, 23:46 UTC

Medtronic PLC shares are trading higher in after-market hours, continuing an upward trend and supported by positive sentiment in European markets.

24 juil. 2026, 23:26 UTC

Medtronic PLC's after-market trading remains roughly flat, showing routine performance within a narrow range since Friday's close.

23 juil. 2026, 23:02 UTC

Medtronic PLC shares are trading higher in after-market hours, reaching near the top of their one-month trading range amid broader market stability.

22 juil. 2026, 19:36 UTC

News

Medtronic PLC shares are lower as competition increases from Johnson & Johnson's newly authorized Ottava Surgical Robot for U.S. robotic soft-tissue surgery.

21 juil. 2026, 20:07 UTC

News

Medtronic PLC shares are lower today, impacted by declines in the Health Care Equipment sector. The company recently launched its AI-native surgical platform, Touch Surgery™ Aide.

20 juil. 2026, 22:31 UTC

Medtronic PLC shares are higher in after-market hours, reflecting positive movement in the Health Care Equipment sub-sector. The stock remains above its 20-day moving average.

Comparaison

Variation de prix

Medtronic PLC prévision

Objectif de Prix

By TipRanks

5.46% hausse

Prévisions sur 12 Mois

Moyen 95.53 USD 5.46%

Haut 118 USD

Bas 80 USD

Basé sur 19 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

19 ratings

Achat

Maintien

Vente

Basé sur 19 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Sentiment

By Acuity

58 / 340Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.